DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis

Immunological Reviews
Ralph A ReisfeldRong Xiang

Abstract

Four novel oral DNA vaccines provide long-lived protection against melanoma, colon, breast, and non-small cell lung carcinoma in mouse model systems. The vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and are directed against targets such as carcinoembryonic antigen, tyrosine-related protein, vascular endothelial growth factor receptor-2 [also called fetal liver kinase-1 (FLK-1)], and transcription factor Fos-related antigen-1 (Fra-1). The FLK-1 and Fra-1 vaccines are effective in suppressing angiogenesis in the tumor vasculature. All four vaccines are capable of inducing potent cell-mediated protective immunity, breaking peripheral T-cell tolerance against these self-antigens resulting in effective suppression of tumor growth and metastasis. It is anticipated that such research efforts will contribute toward the rational design of future DNA vaccines that will be effective for prevention and treatment of human cancer.

References

Mar 24, 1989·Cell·A Bachmair, A Varshavsky
Jan 1, 1988·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·J Thompson, W Zimmermann
Jan 1, 1985·Critical Reviews in Oncology/hematology·J E Shively, J D Beatty
Jun 1, 1993·Current Opinion in Immunology·N Hogg, R C Landis
Feb 1, 1996·Nature Medicine·J Folkman
Jun 1, 1996·Nature Medicine·M S O'ReillyJ Folkman
Jun 1, 1997·Nature Biotechnology·J Folkman
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·J Folkman
Dec 5, 1998·Seminars in Immunology·P Matzinger
Jan 30, 1999·Frontiers in Bioscience : a Journal and Virtual Library·N OrtegaJ Plouët
Apr 21, 1999·Current Opinion in Cell Biology·C A Chambers, J P Allison
Feb 10, 2000·The American Journal of Pathology·D S O'ConnorD C Altieri
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·R XiangR A Reisfeld
May 10, 2000·The Oncologist·G McMahon
Jun 3, 2000·Annual Review of Immunology·S GurunathanR A Seder
Aug 18, 2000·Cancer Immunology, Immunotherapy : CII·S MizobataF J Primus
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K D MillerG W Sledge
Feb 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·J Folkman
Mar 13, 2001·Annual Review of Immunology·K NakanishiH Okamura
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·K J MaloyT M Kündig
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R M SimonJ A Berzofsky
Nov 17, 2001·Current Opinion in Pharmacology·G Taraboletti, B Margosio
Oct 3, 2002·Nature Reviews. Cancer·James E Darnell
Oct 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jon M WiggintonRobert H Wiltrout
Nov 5, 2002·Nature Medicine·Andreas G NiethammerRalph A Reisfeld
Jul 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yunping LuoRong Xiang
Oct 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Guido BocciRobert S Kerbel

❮ Previous
Next ❯

Citations

Jun 11, 2005·Cancer Immunology, Immunotherapy : CII·Constantin N BaxevanisMichael Papamichail
Mar 15, 2011·Cancer Immunology, Immunotherapy : CII·Ben-Jiang QianHui-Zhang Li
Jun 2, 2005·Nature Reviews. Cancer·Dario Neri, Roy Bicknell
Jan 7, 2014·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H J M FergusonR Bicknell
Mar 20, 2010·Seminars in Immunology·Yvonne PatersonLaurence M Wood
Nov 22, 2008·Atherosclerosis·Arnaud D HauerJohan Kuiper
Sep 29, 2006·Advanced Drug Delivery Reviews·Anna K NowakBruce W S Robinson
Aug 1, 2006·Pharmacology & Therapeutics·Eva Untersmayr, Erika Jensen-Jarolim
Jun 21, 2006·Gene·Matthew R Young, Nancy H Colburn
Jun 23, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hesham H SalmanJuan M Irache
Sep 18, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yan ChenXi Cai Wang
Jan 19, 2013·Expert Opinion on Therapeutic Targets·Madelon PaauweLukas J A C Hawinkels
Apr 6, 2007·The Journal of Gene Medicine·Caroline AgorioJose Alejandro Chabalgoity
May 13, 2008·Expert Review of Anticancer Therapy·Richard G EversonJohn H Sampson
Jul 18, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bin ChouKunisuke Himeno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.